Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2006 Feb 13;24(7):904-13. Epub 2005 Sep 12.

Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.

Author information

  • 1Emory University School of Medicine, Department of Pediatrics, Atlanta, GA, USA.

Abstract

Using incidence rates from CDC's Active Bacterial Core surveillance and immunogenicity data from the Navajo/Apache trial of pneumococcal conjugate vaccine (PCV), we used Markov modeling to predict the optimal age to give a single dose of PCV. Antibody concentration thresholds of 0.35 and 1.0 mcg/ml were considered protective. Our outcome was vaccine serotype-specific invasive pneumococcal disease (IPD) incidence at 24 months. The models predicted the optimal age to vaccinate is 5-7 months with vaccine-induced immunologic memory and 8-10 months without memory. IPD reduction ranged from 15 to 62%, depending on model parameters. A single PCV dose in infants could prevent substantial IPD.

PMID:
16203059
DOI:
10.1016/j.vaccine.2005.08.092
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center